| Financial Year |
March 31 2023 |
| Monetary Funds |
57,687,542.06 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
13,629,016.04 |
| Advances to Suppliers |
4,735,970.59 |
| Other Receivables |
6,786,937.91 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
20,531,908.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,893,313.87 |
| Total Current Assets |
111,264,688.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
59,689,082.11 |
| Fixed Assetes |
2,683,688.77 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
344,620.34 |
| R&D expenses |
-- |
| Goodwill |
159,131,982.94 |
| Long-Term Deferred and Prepaid Expenses |
1,393,808.21 |
| Deferred Income Tax Assets |
14,816,552.34 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
257,330,762.02 |
| Total Assets |
368,595,450.49 |
| Short-Term Loans |
20,035,444.45 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
46,944,290.68 |
| Accounts Received In Advance |
133,173.27 |
| Employee Compensation Payable |
30,880,859.20 |
| Taxes Payable |
1,991,104.32 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,457,833.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,212,933.20 |
| Other Current Liabilities |
2,351,144.02 |
| Sub-Total of Current Liabilities |
154,195,189.53 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
8,551,644.99 |
| Total Liabilities |
162,746,834.52 |
| Paid-In Capital(Or Share Stock) |
559,464,188.00 |
| Capital Surplus |
1,127,546,332.30 |
| Surplus Reserve |
8,589,664.18 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,516,171,652.84 |
| Minority Stockholder's Interest |
27,032,084.33 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
178,816,531.64 |
| Owner's Equity（Stockholder's Equity） |
205,848,615.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
368,595,450.49 |
